(118) quantitatively identified CD91 as a LUAD-specific antigen on exosomes through a comprehensive analysis of 1369 exosome protein profiles, serving as a screening marker for lung cancer that is unaffected by gender or age. This evidence concerns the gene LRP1 and lung carcinoma.